|with t-1249 dead, now what?
Jan 9, 2004
With the approval of t-1249 put on halt in clinical trials what is the next agent in the pipeline that is working to take it's place?
| Response from Dr. Young
The development of T1249 has been halted, not it's approval, per se.
There are other compounds in development, like CCR5 inhibitors that might work in complementary ways-- these are still in very early stages of clinical discovery; until we see more advanced studies, the prevention of HIV entry into cells will still depend on the existing (and FDA-approved) fusion inhibitor, enfuvirtide (T-20, Fuzeon). BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.